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Abstract 
Glycosylation reactions of the ethylthio, bromo, and chloro derivatives of 1-deoxy-1-
ethoxysulfonyl-hept-2-ulopyranose were studied applying different acceptors under different 
conditions. Elimination side-reactions affording exo- and endoglycals occured in all cases, 
however, with different proportions. Glycosyl chloride donor was applied to glycosylate a 
trisaccharide acceptor obtaining a new sulfonic acid mimetic of the sialyl Lewis X 
tetrasaccharide in high yield.  
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1. Introduction 
Selectins are carbohydrate-binding transmembrane glycoproteins, and their role is to mediate 
the first steps of the recruitment of leukocytes from the blood stream in a series of normal and 
pathologic situations.1 Control of these processes by inhibiting the adhesion between the 
calcium-dependent lectin domain of selectins and their carbohydrate ligands has been 
considered as a new anti-inflammatory and anti-metastatic strategy.2 Sialyl Lewis X (sLex) 
tetrasaccharide, one of the major natural ligands of selectins serves as a lead-structure for the 
design of selectin antagonists (Figure 1).3 The negatively charged carboxylate of sialic acid is 
crucial in binding to transmembrane proteins, but it can be replaced by other charged 
moieties. Analogues containing e.g. sulfate ester,4 phosphate ester5 or cyclohexyl lactic acid6 
instead of sialic acid proved to be active as selectin antagonists. 
Earlier, we described the synthesis of sulfonic acid analogues of the sLe X tetrasaccharide in 
which the sialic acid is replaced by an anomeric sulfonomethyl-type sugar moiety.7,8 To 
install the sulfonomethyl derivative to oligosaccharides ethyl 3,4,5,7-tetra-O-benzyl-1-deoxy-
1-ethoxysulfonyl-2-thio--D-gluco-hept-2-ulopyranoside was used as glycosyl donor. 
However, the yields of glycosylation reactions were moderate since a considerable amount of 
exo-glycal was always formed via elimination side-reaction.  
Recently, two isosteric sulfonate mimetics of mannose-6-O-phosphate prepared by 
Wadsworth-Horner-Emmons olefination have been published.9 Both conjugated and 
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unconjugated mannose-sulfonates displayed better binding affinity to cation-independent 
mannose-6-phosphate receptor and possessed greater stability in human serum than mannose-
6-phosphate. 
We have found that sulfonate analogues of idraparinux, a synthetic non-glycosaminoglycan 
anticoagulant pentasaccharide inhibited efficiently the blood coagulation factor Xa in an in 
vitro assay.10 
The experimental evidence of biological activity of carbohydrate sulfonic acids inspired us to 
revisit the synthesis of sulfonic acid mimetic of sialic acid-containing oligosaccharides using 
anomeric sulfonomethyl-type donors. 
Here, we report glycosylation reactions of ethylthio, chloro and bromo derivatives of 3,4,5,7-
tetra-O-benzyl-1-deoxy-1-ethoxysulfonyl--D-gluco-hept-2-ulopyranose applying different 
acceptors and conditions. Efficient synthesis of a new sulfonic acid tetrasaccharide analogue 
of the sialyl Lewis X is also discussed. 
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Figure 1. Structure of the sialyl Lewis X tetrasaccharide 
 
2. Results and discussion 
2.1. Glycosylation study 
Thioglycoside 2,7,8 and the appropriate bromo (3) and chloro (4) derivatives were planned to 
be utilized as glycosyl donors. Compound 2 was treated with bromine to produce 3; the 
reaction went to completion in ten minutes. The chlorosugar 4 was prepared from the 
hemiketal 1 using thionyl chloride and pyridine as reagents (Scheme 1).  
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Scheme 1. Reagents and conditions: i) EtSH, BF3Et2O, abs CH2Cl2, 0 °C, 93% ii) Br2, abs 
DCM, 0 °C, 10 min, iii) SOCl2, py, abs CH2Cl2, rt, 10 min, 85%. 
 
The obtained 2-4 were used as donors to glycosylate methanol (Scheme 2), acceptor 911 
containing free hydroxyl group at primary position (Scheme 3), and acceptors 1211 and 1312 
with secondary alcoholic functions (Scheme 4), respectively. NIS-TfOH promoter system was 
applied at different temperatures to activate the thioglycoside, and MeOTf was also used as a 
promoter for glycosylation of 12 and 13.13 Halide donors, prepared freshly before 
glycosylations and used without purification, were activated with either AgOTf or Hg(CN)2, 
and chloro sugar was promoted also with a mixture of Hg(CN)2 and HgBr2. Relative 
proportions of the products were determined from the crude reaction mixture by HPLC 
measurements. 
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Scheme 2. Reagents and conditions: i) MeOH (15 equiv), 3  MS, for solvents and promoters 
see Table 1. 
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The glycosylation results using methanol as an acceptor (Scheme 2) are summarized in Table 
1. Each reaction afforded an anomeric mixture of the methyl glycosides 5 and 6.13 Using the 
thioglycoside donor 2 the stereoselectivity was poor in favour of either the α- or the β-anomer 
depending on the reaction temperature. Reactions applying halide donors 3 and 4 provided the 
α-isomer 5 as the major product with high stereoselectivity. From the chloro and bromo-
sugars the known elimination side-product 77,8 was formed in all cases, and upon AgOTf 
promotion the endoglycal 8 as another side-product was observed as well. 
 
Table 1. Glycosylation of methanol with 1-deoxy-1-ethloxysulfonyl-hept-2-ulopyranosyl 
donors 
 
aAmount of promoters: NIS (1.2 equiv) TfOH (0.4 equiv); Hg(CN)2 (1 equiv); AgOTf (2 
equiv); Hg(CN)2-HgBr2 (1.5 equiv-0.5 equiv). Solvents: CH2Cl2 for entries 1-3, CH2Cl2-
toluene for entries 4 and 6, CH2Cl2-CH3CN for entries 5 and 7. 
 
Glycosylation reactions using acceptor 9 possessing a reactive primary hydroxyl (Scheme 3) 
are summarized in Table 2. In each case a mixture of the stereoisomeric 2,6-linked 
disaccharides 10 and 1111 together with elimination side-product(s) was formed. Reactions 
using thioglycoside gave the disaccharides with the highest proportion and the highest α-
Entry Donor Promotera T (°C) Time 5 (%) 6 (%) 7 (%) 8 (%) 
1 2 NIS-TfOH -60 40 min 43 57 - - 
2 2 NIS-TfOH 0 40 min 62 38 - - 
3 2 NIS-TfOH rt 30 min 69 31 - - 
4 3 AgOTf -40 to -10 20 min 81.3 17.6 0.7 0.4 
5 3 Hg(CN)2 0 20 min 65.2 33.1 1.6 - 
6 4 AgOTf -40 to -10 5 h 80.7 12.0 5.4 1.9 
7 4 Hg(CN)2-HgBr2 0 to rt 5 h 84.9 9.5 5.6 - 
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selectivity; by using chloro- and bromo sugars upon AgOTf promotion at –15 oC a slightly 
lower rate of disaccharides and lower stereoselectivity were achieved. For both halide donors 
the rate of glycosylation decreased using Hg(II) salt instead of Ag(I) salt. Carrying out 
glycosylation with donor 4 of low reactivity using less powerful activation the glycoside 
formation decreased dramatically and elimination reactions became the dominant reactions 
(Entry 7).  
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Scheme 3. Reagents and conditions: see Table 2. 
 
Table 2. Glycosylation of 9 with 1-deoxy-1-ethoxysulfonyl-hept-2-ulopyranosyl donors 
 
Entry Donor Promotera T (°C) Time 10 (%) 11 (%) 7 (%) 8 (%) 
1 2 NIS-TfOH -50 1 h 81.6 6.7 11.7 - 
2 2 NIS-TfOH -5 30 min 74.4 7.7 17.9 0 
3 3 AgOTf -15 7.5 h 63.6 24.0 12.4b 
4 3 Hg(CN)2 0 3 h 55.2 19.4 25.4b 
5 4 AgOTf -15 8 h 71.5 6.3 19.8 2.4 
6 4 Hg(CN)2-HgBr2 0 18 h 55.8 19.6 24.6b 
7 4 Hg(CN)2 rt 18 h 11.3 8.5 57.1 23.1 
aAmount of promoters: NIS (1.2 equiv) TfOH (0.4 equiv); Hg(CN)2 (1 equiv); AgOTf (2 
equiv); Hg(CN)2-HgBr2 (1.5 equiv-0.5 equiv). bRatio of 7 and 8 was not determined. Solvents: 
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CH2Cl2 for entries 1-2, CH2Cl2-toluene for entries 3 and 5, CH2Cl2-CH3CN for entries 4, 6 
and 7. 
 
Glycosylation reactions using acceptor 12 and 13 (Scheme 4) are summarized in Tables 3 and 
4. The main features of these reactions were that elimination reactions generally overtook 
glycoside formation, and the α-linked disaccharides formed exclusively. Configuration of the 
interglycosidic linkages of 14 and 15 was determined on the basis of the NMR C1–H3 three-
bond coupling constant which is dependent on the dihedral angle in a manner similar to 
3JH,H.13  
Thioglycoside 2 upon powerful activation using NIS-TfOH was inefficient for glycosylation 
of the unreactive acceptors 12 and 13; reactivity of the secondary hydroxyl groups was low at 
the low temperature of activation (-40 °C), therefore oxocarbenium intermediate formed 
rapidly from the donor was stabilized via elimination (Table 3: entries 1, 2 and Table 4: entry 
1). Slow activation process of 2 at room temperature using the mild MeOTf as a promoter 
gave slightly better results, due to the increasing reactivity of the acceptor at higher 
temperature (Table 3: entry 3 and Table 4: entry 2). Beside exoglycal 7, formation of 
endoglycal 8 from thioglycoside was also observed. 
Glycosyl halides proved to be more efficient donors for both acceptors 12 and 13 than the 
thioglycoside. Interestingly, the outcome of the reactions was greatly influenced by the 
aglycons of the acceptors (α-methyl for 12 and β-p-methoxyphenyl for 13). For acceptor 12 
the more reactive halide donor 3 with the less powerful promoter Hg(CN)2 worked as well 
than the less reactive halide donor 4 with the more powerful promoter AgOTf (Table 3: 
entries 5 and 6). For acceptor 13 chlorosugar 4 upon AgOTf promotion worked much better 
than bromosugar 3 activated by Hg(CN)2 (Table 4: entries 5 and 4). 
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Scheme 4. Reagents and conditions: see Table 3 and 4. 
 
Table 3. Glycosylation of 12 with 1-deoxy-1-ethoxysulfonyl-hept-2-ulopyranosyl donors 
 
Entry Donor Promotera T (°C) Time 14 (%) 7 (%) 8 (%) 
1 2 NIS-TfOH -40 30 min 17.4 55.1 27.5 
2 2 NIS-TfOH 0 2 h 0.6 99.4b 
3 2 MeOTf rt 1 day 23.2 76.8b 
4 3 AgOTf 0 1 h 28.6 40.8 30.6 
5 3 Hg(CN)2 0 1h 39.6 35.0 25.4 
6 4 AgOTf 0 1h 40.0 45.2 14.8 
7 4 Hg(CN)2-HgBr2 0 4 days 11.2 62.0 26.8 
aAmount of promoters: NIS (1.2 equiv) TfOH (0.4 equiv); MeOTf (6 equiv); AgOTf (2 
equiv); Hg(CN)2 (1 equiv); Hg(CN)2-HgBr2 (1.5 equiv-0.5 equiv). bRatio of 7 and 8 was not 
determined. Solvents: CH2Cl2 for entries 1-3, CH2Cl2-toluene for entries 4 and 6, CH2Cl2-
CH3CN for entries 5 and 7. 
 
 
Table 4. Glycosylation of 13 with 1-deoxy-1-ethoxysulfonyl-hept-2-ulopyranosyl donors 
 
Entry Donor Promotera T (°C) Time 15 (%) 7 (%) 8 (%) 
1 2 NIS-TfOH -40 65 min 12.0 86.1 1.9 
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2 2 MeOTf RT 1 day 18.5 81.5b 
3 3 AgOTf 0 2 h 13.5 30.5 56.0 
4 3 Hg(CN)2 0 2.5 h 16.2 29.3 54.5 
5 4 AgOTf 0 2 days 63.4 29.1 7.5 
6 4 Hg(CN)2-HgBr2 0 5 days 16.3 50.7 33.0 
aAmount of promoters: NIS (1.2 equiv) TfOH (0.4 equiv); MeOTf (6 equiv); AgOTf (2 
equiv); Hg(CN)2 (1 equiv); Hg(CN)2-HgBr2 (1.5 equiv-0.5 equiv). bRatio of 7 and 8 was not 
determined. Solvents: CH2Cl2 for entries 1-2, CH2Cl2-toluene for entries 3 and 5, CH2Cl2-
CH3CN for entries 4 and 6. 
 
 
Summarising the results, using ketosyl donors carrying a sulfonomethyl moiety at the 
anomeric position the outcome of glycosylation reactions strongly depends on the reactivity 
of the acceptor. The oxocarbenium ion formed upon activation can react with the aglycon to 
form glycoside, or can transform easily to glycal derivatives via elimination of the labile 
proton next to the electron withdrawing sulfonic acid moiety. The ratio of glycosylation and 
elimination is determined by the relative rate of formation of the oxocarbenium cation, its 
reaction with the acceptor and the elimination reaction from the oxocarbenium intermediate.  
During glycosylation of methanol, the elimination was negligible, independently of the 
applied donor or promoter, due to the immediate reaction of the oxocarbenium ion with the 
highly reactive alcohol. In the reactions of acceptor 9 containing a primary hydroxyl, at lower 
temperature glycoside formation was more favoured. Accordingly, more reactive donor 
afforded better results. 
Acceptors with low reactivity could not be glycosylated at low temperature, therefore 
application of reactive donors and promoters should be avoided. Increasing the temperature 
both glycosylation and elimination became faster, and an optimum of their relative rates can 
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lead to better results. In our case, the chlorosugar with the lowest reactivity proved to be the 
best donor to glycosylate 12 and 13. 
 
2.2. Synthesis of a new sialyl Lewis X mimic 
 
Synthesis of tetrasaccharide 21 as a new sulfonic acid analogue of the sialyl Lewis X was 
carried out as shown on Scheme 5. It is known from SAR study of the sLex tetrasaccharide 
analogues, that 2-acetamido group of its glucosamine residue is not involved in binding to 
selectins, therefore the cheap and easily available lactose could be used for the synthesis 
instead of lactosamine. The 3’,4’-O-isopropylidene derivative of p-methoxyphenyl lactoside 
1614 was converted to crystalline 17 in high yield by the well-established selective 
benzoylation.15 Fucosylation of acceptor 17 with ethyl 2,3,4-tri-O-benzyl-1-thio-β-L-fucoside 
1816 upon TMSOTf activation afforded the Lewis X mimetic 19. Deisopropylidenation of the 
fully protected trisaccharide using methanolic HCl17 gave 20 without affecting the highly acid 
sensitive α-fucosidic linkage. Then the diol was glycosylated with both thioglycoside 2 and 
chlorosugar 4, as to consider their capacity in forming a tetrasaccharide. Based on our 
glycosylation experiments discussed above, higher yield was expected using donor 4. 
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Scheme 5. Reagents and conditions: i) BzCl, toluene-py, 0°C, 1.5 h, 69% ii) abs CH2Cl2, 
NIS-TMSOTf, -45°C, 1 h, 94% iii) 1M HCl, MeOH, 50°C, 3 h, 89% iv) (a) donor 4, AgOTf, 
abs CH2Cl2, 0°C, 12h, 59% for 21, 28 % for 7 + 8 (b) donor 2, MeOTf, abs CH2Cl2, rt, 33% 
for 21, 38% for 7 + 8 (c) donor 2, NIS-TfOH, abs CH2Cl2, rt, 10% for 21, 42% for 7 + 8. 
 
In the reactions of thioglycoside 2 elimination took place dominantly, and the desired 
tetrasaccharide formed only in moderate yields. Glycosylation of 20 with the chloride donor 4 
resulted in the target compound 21 in considerably higher yield, according to our expectation. 
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In conclusion, this investigation of glycosylation reactions of the ethylthio, bromo, and chloro 
derivatives of 1-deoxy-1-ethoxysulfonyl-hept-2-ulopyranose revealed, that activation methods 
and reactivity of the donors should be matched to the reactivity of acceptors in order to 
achieve high yield in glycosylations. Glycosyl chloride donor 4 with moderate reactivity was 
applied successfully to glycosylate a trisaccharide acceptor affording a new sialyl Lewis X 
mimetic in acceptable yield. Further exploitation of glycosylation with anomeric 
sulfonomethyl-containing donors in synthesis of oligosaccharides of potential biological 
activity is in progress in our laboratory. 
 
3. Experimental 
 
3.1. General methods 
Optical rotations were measured at room temperature with a Perkin-Elmer 241 automatic 
polarimeter. TLC was performed on Kieselgel 60 F254
 
(Merck) with detection by immersing 
into 5% ethanolic sulfuric acid soln followed by heating. Column chromatography was 
performed on Silica gel 60 (Merck 0.063-0.200 mm) and Sephadex LH-20 (Sigma-Aldrich, 
Bead size 25-100 µ). Organic solutions were dried over MgSO4, and concentrated in vacuum. 
The 1H (200, 360, 400 and 500 MHz) and 13C NMR (50.3, 90.54, 100.28, 125.76 MHz) 
spectra were recorded with Bruker AC-200, Bruker DRX-360, Bruker DRX-400 and Bruker 
DRX-500 spectrometers. Chemical shifts are referenced to Me4Si (0.00 ppm for 1H) or to the 
residual solvent signals (CDCl3: 77.00 ppm for 13C). MALDI-TOF MS analyses of the 
compounds were carried out in the positive reflectron mode using a BIFLEX III mass 
spectrometer (Bruker, Germany) equipped with delayed-ion extraction. The matrix solution 
was a satd 2,4,6-trihydroxy-acetophenone (THAP) solution in MeCN. A Hewlett-Packard 
1090 series II Liquid Chromatograph equipped with a diode array detector (DAD), an 
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automatic samples and Chem Station were used for the separation experiments. The 
separation was performed using a Supelcosil Si 5µm column. n-Hexane/ethyl-acetate mixture 
was used as eluent. The effluent was monitored for UV-active groups at 256 nm. The 
component ratio was given on the basis of the Area% of the HPLC analysis. 
 
3.2. General method A for glycosylation of methanol starting from thioglycoside 2 
 
To a solution of 1 mmol thioglycoside donor (1 equiv) in dry CH2Cl2 (15 mL) 3 Å molecular 
sieves and methanol (15 equiv) were added and it was stirred for 3 h. The reaction mixture 
was cooled to the appropriate temperature then the solution of NIS (1.2 equiv) and TfOH (0.4 
equiv) in dry CH2Cl2 and THF (1:1, 2 mL) was added. When TLC showed complete 
conversion of the donor, the reaction mixture was quenched with Et3N, the insoluble materials 
were removed by filtration, the filtrate was diluted with CH2Cl2 and washed with water, 
filtered, dried and concentrated. The ratio of the products was determined from the crude 
product by HPLC. 
 
3.3. General method B for glycosylation of methanol with halide donor 3 or 4 
 
I) To a solution of methanol (15 equiv) in toluene (2.5 mL) 3 Å molecular sieves and AgOTf 
(2 equiv) were added and it was stirred for 3 h. The reaction mixture was cooled to the 
appropriate temperature then the solution of donor (1 equiv) in dry CH2Cl2 (2 mL/0.3 mmol) 
was added. When TLC showed complete conversion of the donor, the insoluble materials 
were removed by filtration, the filtrate was diluted with CH2Cl2, washed with 10% Na2S2O3-
solution and water, filtered, dried and concentrated. The ratio of the products was determined 
from the crude product by HPLC. 
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II) A mixture of methanol (15 equiv) in dry CH3CN (2.5 mL), powdered 3 Å molecular sieves 
and (HgCN)2 (1 equiv) or Hg(CN)2 (1.5 equiv) and HgBr2 (0.5 equiv) was stirred for 3 h. The 
reaction mixture was cooled to 0 °C then the solution of donor (1 equiv) in dry CH2Cl2 (2 
mL/0.3 mmol) was added. When TLC showed complete conversion of the donor, the 
insoluble materials were removed by filtration, the filtrate was diluted with CH2Cl2, washed 
with 10% Na2S2O3-solution and water, filtered, dried and concentrated. The ratio of the 
products was determined from the crude product by HPLC. 
 
3.4. General method C for preparation of glycosides 5, 6, 10, 11, 14 and 15 starting from 
donor 2 
 
To a solution of acceptor (1.5 equiv) and donor (1 equiv) in dry CH2Cl2 (15 mL/mmol) 4 Å 
molecular sieves was added and it was stirred for 3 h. The reaction mixture was cooled to the 
appropriate temperature then the solution of NIS (1.2 equiv) and TfOH (0.4 equiv) in dry 
CH2Cl2 and THF (1:1, 2 mL) was added. When TLC showed complete conversion of the 
donor, the reaction was quenched with Et3N, the insoluble materials were removed by 
filtration, the filtrate was diluted with CH2Cl2, washed with water, filtered, dried and 
concentrated. The obtained crude product was used for HPLC measurements. 
 
3.5. General method D for preparation of glycosides 14 and 15 starting from donor 2 
using MeOTf 
 
To a solution of acceptor (1.5 equiv) and donor (1 equiv) in dry CH2Cl2 (15 mL/mmol) 4 Å 
powdered molecular sieves was added and it was stirred for 3 h, then MeOTf (6 equiv) was 
added. When TLC showed complete conversion of the donor, the reaction was quenched with 
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Et3N, the insoluble materials were removed by filtration, the filtrate was diluted with CH2Cl2, 
washed with water, filtered, dried and concentrated. The ratio of the products was determined 
from the crude product by HPLC. 
 
3.6. General method E for preparation of glycosides 5, 6, 10, 11, 14 and 15 with halide 
donors 3 and 4 
I) To a solution of acceptor (1.5 equiv) in toluene (2.5 mL) 4 Å molecular sieves and AgOTf 
(2 equiv) were added and it was stirred for 3 h. The reaction mixture was cooled to the 
appropriate temperature then the solution of donor (1 equiv) in dry CH2Cl2 (2 mL/0.3 mmol) 
was added. When TLC showed complete conversion of the donor, the insoluble materials 
were removed by filtration, the filtrate was diluted with CH2Cl2, washed with 10% Na2S2O3-
solution and water, filtered, dried and concentrated. The ratio of the products was determined 
from the crude product by HPLC. 
II) A mixture of acceptor (1.5 equiv) in dry CH3CN (2.5 mL), powdered 4 Å molecular sieves 
and (HgCN)2 (1 equiv) or Hg(CN)2 (1.5 equiv) and HgBr2 (0.5 equiv) was stirred for 3 h. The 
reaction mixture was cooled to 0°C then the solution of donor (1 equiv) in dry CH2Cl2 (2 
mL/0.3 mmol) was added. When TLC showed complete conversion of the donor, the 
insoluble materials were removed by filtration, the filtrate was diluted with CH2Cl2, washed 
with 10% Na2S2O3-solution and water, filtered, dried and concentrated. The ratio of the 
products was determined from the crude product by HPLC. 
 
3.7. 3,4,5,7-Tetra-O-benzyl-1-deoxy-1-ethoxysulfonyl-α-D-gluco-hept-2-ulopyranosyl-
bromide (3) 
 
To a stirred solution of 2 (212 mg, 0.30 mmol) in abs dichloromethane (2 mL), 15 L (0.30 
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mmol, 1.0 equiv) bromine was added and it was cooled to 0 oC. The reaction mixture was 
concentrated after 10 min and the residue was coevaporated 3 times with toluene. The 
obtained syrupy crude product (218 mg) was used for further reaction without purification. Rf 
0.75 (98:2 CH2Cl2-acetone). 
 
3.8. 3,4,5,7-Tetra-O-benzyl-1,2-dideoxy-1-ethoxysulfonyl-α-D-gluco-hept-2-ulopyranosyl-
chloride (4) 
 
Compound 1 (700 mg, 0.99 mmol) was dissolved in 5 mL abs dichloromethane and 55 L 
(0.99 mmol, 1.0 equiv) pyridine and 85 L (1.09 mmol, 1.1 equiv) SOCl2 were added at room 
temperature. After 10 min the reaction mixture was diluted with CH2Cl2, washed twice with 
1M aq HCl, 1M aq NaHCO3 and water, then it was dried, filtered, evaporated and purified by 
column chromatography, to give 4 (625 mg, 85%). For glycosylation, the syrupy crude 
product was used without purification. Rf 0.81 (n-hexane-EtOAc 7:3); 1H NMR (200 MHz, 
CDCl3): δ 7.38-7.12 (m, 20H, Ph), 5.04 (m, 7H, J 11.9 Hz, CH2Ph), 4.59 (d, 1H, J 9.2 Hz), 
4.50 (d, 1H, J 12.1 Hz, CH2Ph), 4.28-4.13 (m, 3H, SO3CH2CH3), 4.13-4.06 (m, 1H), 3.80 (d, 
1H, J 15.1 Hz, H-1a), 3.82-3.72 (m, 3H), 3.69 (d, 1H, J 15.1 Hz, H-1b), 1.22 (t, 3H, J 7.1 Hz, 
SO3CH2CH3); 13C NMR (50 MHz, CDCl3) δ 138.1, 137.9 (4C, Cq, Ph), 128.5-125.6 (20C, 
Ph), 104.3 (C-2), 83.6, 79.8, 76.7, (C-3, C-4, C-5), 75.6, 75.2, 75.1, 73.3 (4C, CH2Ph), 68.0 
(2C, C-7, SO3CH2CH3), 57.9 (C-1), 15.0 (SO3CH2CH3); MALDI-TOF m/z Calcd for 
C37H41ClNaO8S+ [M+Na]+: 703.21, Found: 703.21. 
 
3.9. 2,6-Anhydro-3,4,5,7-tetra-O-benzyl-1-ethoxysulfonyl-D-gluco-hept-2-enitol (8) 
Isolated as a colourless syrup (14%) from the reaction of 4 and 9 according to general method 
E, II, using Hg(CN)2 as a promoter. [α]D -4.3 (c 0.07, CHCl3); Rf 0.60 (99:1 CH2Cl2-acetone); 
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1H NMR (400 MHz, CDCl3): δ 7.34-7.25 (m, 20H, Ph), 4.85-4.48 (m, 8H, CH2Ph), 4.39 (d, 
1H, J 4.2 Hz, H-4), 4.27-4.21 (m, 3H, H-6, SO3CH2CH3), 4.06-3.97 (m, 3H, H-5, C-1-CH2), 
3.83-3.75 (m, 2H, C-7a,b), 1.25 (t, 3H, J 7.1 Hz, SO3CH2CH3); 13C NMR (100 MHz, CDCl3): 
δ 137.9, 137.7, 137.6, 136.9 (4C, Cq, Ph), 136.1, 135.7 (C-2 and C-3), 128.4-127.6 (20C, Ph), 
76.5 (C-6), 73.5 (C-4), 72.6 (C-5), 73.6, 73.4, 72.5, 70.4 (4C, 4 x CH2Ph), 67.9 
(SO3CH2CH3), 67.8 (C-7), 49.7 (C-1), 15.0 (SO3CH2CH3); Anal. Calcd for: C37H40O8S 
(644.77): C, 68.92; H, 6.25; S, 4.97. Found: C, 68.79; H, 6.29; S, 5.00. 
 
3.10. Methyl 2,3,6-tri-O-benzyl-4-O-(3,4,5,7-tetra-O-benzyl-1-deoxy-1-ethoxysulfonyl-α-
D-gluco-hept-2-ulopyranosyl)-β-D-glucopyranoside (14) 
 
Compound 14 was prepared from donor 2 and acceptor 12 by method C and donor 3 or 4 and 
acceptor 12 by method E (see Table 3). [α]D +33.1 (c 0.19, CHCl3); Rf 0.69 (98:2 CH2Cl2-
acetone); 1H NMR (500 MHz, CDCl3) δ 7.33-7.14 (m, 35H, Ph), 4.95-4.84 (m, 5H, CH2Ph), 
4.77 (d, 1H, J 11.1 Hz, CH2Ph), 4.66 (d, 1H, J 11.2 Hz, CH2Ph), 4.60-4.57 (m, 5H, H-1, 
CH2Ph), 4.51-4.42 (m, 3H, CH2Ph), 4.21-4.14 (m, 4H, H-1’a, H-5’, H-6’, H-7’a), 4.05 (t, 1H, 
J 9.0 Hz, H-4), 4.00 (dd, 1H, J 10.0 Hz, J 5.0 Hz, H-3’), 3.91-3.89 (m, 1H, H-3), 3.86 (q, 2H, 
J 7.0 Hz, SO3CH2CH3), 3.73-3.70 (m, 3H, H-1’b, H-5, H-6a), 3.67-3.62 (m, 2H, H-4’, H-6b), 
3.55 (d, 1H, J 11.3 Hz, H-7’b), 3.45 (dd, 1H, J1,2 3.3 Hz, J2,3 9.5 Hz, H-2), 3.36 (s, 3H, 
OCH3), 1.08 (t, 3H, J 7.05 Hz, SO3CH2CH3 ); 13C NMR (125 MHz, CDCl3) δ 139.1-137.8 
(7C, Cq, Ph), 128.6-126.8 (35C, Ph), 99.9 (C-2’), 97.3 (C-1), 82.4 (C-5’), 81.0 (C-3), 80.4 (C-
6’), 79.4 (C-2), 78.5 (C-4’), 73.2 (C-4), 73.0 (C-3’), 70.3 (C-5), 75.4, 75.3, 75.2, 73.3, 73.2, 
73.1 (7C, CH2Ph), 69.5 (C-7’), 68.9 (C-6), 66.7 (SO3CH2CH3), 55.4 (OCH3), 51.5 (C-1’, 
3JC1’,H3’ ≤ 1 Hz), 14.8 (SO3CH2CH3); Anal. Calcd for: C65H72O14S (1109.32): C, 70.38; H, 
6.54; S, 2.89. Found: C, 69.96; H, 6.33; S, 2.76. 
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3.11. 4-Methoxyphenyl 2,3,6-tri-O-benzyl-4-O-(3,4,5,7-tetra-O-benzyl-1-deoxy-1-
ethoxysulfonyl-α-D-gluco-hept-2-ulopyranosyl)-β-D-glucopyranoside (15) 
 
Compound 15 was prepared from donor 2 and acceptor 13 by method C and from donor 3 or 
4 and acceptor 13 by method E (see Table 4). [α]D +9.8 (c 0.17, CHCl3); Rf 0.85 (97:3 
CH2Cl2-acetone); 1H NMR (500 MHz, CDCl3) δ 7.34-7.16 (m, 35H, Ph), 6.98, 6.79 (2 x d, 
4H, PMP), 5. 07 (d, 1H, J 6.3 Hz), 4.98-4.41 (m, 14H, CH2Ph), 4.23 (d, 1H, J 9.6 Hz), 4.17-
4.11 (m, 3H), 3.96-3.89 (m, 5H), 3.75 (s, 3H, OCH3), 3.71-3.59 (m, 7H), 1.10 (t, 3H, J 7.1 
Hz, SO3CH2CH3); 13C NMR (125 MHz, CDCl3) δ 155.1, 151.2 (2C, Cq, PMP), 138.4-138.0 
(7C, Cq, Ph), 128.3-127.1 (35C, Ph), 118.1, 114.5 (4C, PMP), 102.0 (C-1), 100.1 (C-2’), 82.5, 
80.5, 80.1, 78.3, 76.6, 73.3, 73.2 (skeleton carbons) 75.3, 75.2, 75.0, 74.6, 74.1, 73.4, 73.3 
(6C, CH2Ph), 70.1, 68.9 (C-6 and C-7’), 67.0 (SO3CH2CH3), 55.5 (OCH3), 51.8 (C-1’, 3JC1’,H3’ 
≤ 1 Hz), 14.9 (SO3CH2CH3); Anal. Calcd for C71H76O15S (1200.49): C, 70.98; H, 6.38; S, 
2.67. Found: C, 71.04; H, 6.43; S, 2.59. 
 
3.12. 4-Methoxyphenyl 3,4-O-isopropylidene-2,6-di-O-benzoyl-β-D-galactopyranosyl-
(14)-2,6-di-O-benzoyl-β-D-glucopyranoside (17) 
 
A stirred solution of 16 (970 mg, 2 mmol) in 15 mL of dry pyridin and 20 mL of dry toluene 
was cooled to 0 °C and BzCl (1.85 ml, 16 mmol, 8 equiv) was added dropwise. After 90 min 
MeOH was added and the reaction mixture was concentrated. It was then diluted with EtOAc, 
washed with satd aq NaHCO3 and water, dried, filtered and evaporated. The crude product 
was recrystallized from EtOAc-n-hexane to yield 17 (1.25 g, 69%). Mp 225-227°C, []D +7.6 
(c 0.54, CHCl3); Rf 0.73 (95:5 CH2Cl2-acetone); 1H NMR (200 MHz, DMSO-d6) δ 8.09-7.29 
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(m, 20H, Ph), 6.82, 6.59 (2 x d, 4H, PMP), 5.46 (t, 1H, J 8.5 Hz),5.38 (t, 1H, J 7.6 Hz), 4.7 (d, 
1H, J1,2 8.0 Hz,), 4.87 (d, 1H, J 10.8 Hz), 4.69-4.66 (m, 2H), 4.47-4.28 (m, 6H), 4.06 (t, 1H, J 
9.2 Hz), 3.84-3.75 (m, 2H), 3.65 (s, 3H, OCH3), 1.64, 1.35 (2 x s, 6H, C(CH3)2); 13C NMR 
(50 MHz, DMSO) δ 166.5, 165.4, 165.2 (4C, CO), 155.4, 151.0 (2C, Cq, PMP), 133.3-128.4 
(24C, Ph), 118.7, 114.2 (4C, PMP), 111.2 (C(CH3)2), 101.4 (C-1), 100.5 (C-1’), 82.4, 76.9, 
73.5, 73.4, 72.9, 72.7, 72.1, 72.0 (skeleton carbons), 63.6, 62.7 (C-6 and C-6’), 55.4 (OCH3), 
27.5, 26.2 (C(CH3)2); Anal. Calcd for C50H48O16 (904.29): C, 66.36; H, 5.35. Found: C, 66.37; 
H, 5.34. 
 
3.13. 4-Methoxyphenyl 2,6-di-O-benzoyl-3,4-O-isopropylidene-β-D-galactopyranosyl-
(14)-2,6-di-O-benzoyl-3-O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-β-D-
glucopyranoside (19) 
 
To a stirred solution of acceptor 17 (1.1 g, 1.22 mmol) and donor 18 (0.875 g, 1.83 mmol) in 
dry CH2Cl2 (20 mL) 4 Å molecular sieves was added. After stirring for 1 h the mixture was 
cooled to -45 °C and NIS (36 mg, 1.3 equiv) and TMSOTf (66 µL, 0.3 equiv) dissolved in 
CH2Cl2:THF (1:1, 5 mL) were added. After 1 h the reaction was quenched with pyridine (0.5 
mL), diluted with CH2Cl2 and filtered through Celite. The filtrate was washed with 10% aq 
Na2S2O3 and water, dried and concentrated. The crude product was purified by column 
chromatography (99:1 CH2Cl2-acetone) to yield 19 (1.51 g, 94%) as a colourless syrup. []D 
+13.56 (c 0.649, CHCl3); Rf 0.42 (n-hexane-EtOAc 7:3); 1H NMR (500 MHz, CDCl3) δ 8.12-
6.90 (m, 35H, Ph), 6.65, 6.47 (2 x d, 4H, PMP), 5.58 (t, 1H, J 8.8 Hz), 5.38 (d, 1H, J1”,2” 3.5 
Hz, H-1”), 5.19 (t, 1H, J 8.0 Hz), 4.90-4.69 (m, 6H), 4.61-4.44 (m, 4H), 4.33-4.18 (m, 6H), 
4.11-4.02 (m, 2H), 3.90-3.89 (m, 2H), 3.73 (s, 1H), 3.58-3.54 (m, 1H), 3.53 (s, 3H, OCH3), 
1.43, 1.24 (2 x s, 6H, C(CH3)2), 1.20 (d, 3H, H-6”); 13C NMR (125 MHz, CDCl3) δ 166.3, 
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165.8, 164.6, 164.4 (4C, CO), 155.4, 151.0 (2C, Cq, PMP), 139.0. 138.5, 138.0 (3C, Cq, Ph), 
133.3-126.7 (39C, Ph), 118.6, 114.2 (4C, PMP), 110.7 (C(CH3)2), 100.8 (C-1), 100.3 (C-1’), 
97.3 (C-1”), 79.0, 78.1, 75.5, 73.9, 73.4, 73.2, 73.1, 71.3, 66.4 (skeleton carbons), 74.5, 72.5 
(3C, CH2Ph), 62.5 (C-6 and C-6’), 55.3 (OCH3), 27.6, 26.2 (C(CH3)2), 16.8 (C-6”). Anal. 
Calcd for C77H76O20 (1320.49): C, 69.99; H, 5.80. Found: C, 66.97; H, 5.78. 
 
3.14. 4-Methoxyphenyl 2,6-di-O-benzoyl-β-D-galactopyranosyl-(14)-2,6-di-O-benzoyl-
3-O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-β-D-glucopyranoside (20) 
 
A solution of 19 (1.3 g, 0.19 mmol) in MeOH (25 mL) was treated with 2.5 mL 1M aq HCl at 
50 °C for 3 h. The mixture was concentrated, diluted with CH2Cl2, washed with satd aq 
NaHCO3 and water, dried, filtered and evaporated. The crude product was purified by column 
chromatography (9:1 CH2Cl2-EtOAc) to yield 20 (1.1 g, 89%) as a colourless syrup. []D -
11.6 (c 0.96, CHCl3); Rf 0.52 (9:1 CH2Cl2-EtOAc); 1H NMR (200 MHz, CDCl3) δ 8.12-6.98 
(m, 35H, Ph), 6.81-6.52 (m, 4H, PMP), 5.69 (t, 1H, J 9.0 Hz, H-2), 5.40 (d, 1H, J1”,2” 3.5 Hz, 
H-1”), 5.25 (t, 1H, J 9.0 Hz, H-2’), 4.89-4.53 (m, 11H), 4.39-4.07 (m, 6H), 3.99-3.53 (m, 7H), 
3.63 (s, 3H, OCH3), 1.32 (d, 3H, H-6”); 13C NMR (50 MHz, CDCl3) δ 166.5, 166.2, 166.0, 
164.5 (4C, CO), 155.3, 151.1 (2C, Cq, PMP), 139.1-126.7 (35C, Ph), 118.6, 114.2 (4C, PMP), 
100.9 (C-1), 100.1 (C-1’), 97.6 (C-1”), 78.9, 78.3, 75.4, 74.4, 73.5, 71.8, 67.7, 66.5 (skeleton 
carbons), 75.1, 72.6 (3C, CH2Ph), 62.9, 61.7 (C-6 and C-6’), 55.4 (OCH3), 16.5 (C-6”). Anal. 
Calcd for C74H72O20 (1280.46): C, 69.36; H, 5.66. Found: C, 66.34; H, 5.65. 
 
3.15. 4-Methoxyphenyl 3,4,5,7-tetra-O-benzyl-1-deoxy-1-ethoxysulfonyl-α-D-gluco-hept-
2-ulopyranosyl-(13)-2,6-di-O-benzoyl-β-D-galactopyranosyl-(14)-2,6-di-O-benzoyl-3-
O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-β-D-glucopyranoside (21) 
  
 21 
 
To a stirred solution of acceptor 20 (750 mg, 0.57 mmol) and donor 4 (267 mg, 0.38 mmol) in 
dry CH2Cl2 (10 mL) 4 Å molecular sieves was added. After stirring for 1 h the mixture was 
cooled to 0 °C and AgOTf (74 mg, 2 equiv) dissolved in toluene (2 mL) was added. The 
mixture was kept at 0 °C overnight. Insoluble materials were removed by filtration, the filtrate 
was diluted with CH2Cl2, washed with 10% aq Na2S2O3 and water, dried, filtered and 
concentrated. The crude product was purified by column chromatography (6:4 n-hexane-
EtOAc) to yield 21 (710 mg, 59%) as a colourless syrup. 
 
Compound 21 was also prepared from acceptor 20 (250 mg, 0.19 mmol, 1.5 equiv) and donor 
2 (92 mg, 0.13 mmol, 1 equiv) in dry CH2Cl2 (10 mL) by method D using MeOTf (86 µL, 
0.78 mmol, 6 equiv). The crude product was purified by column chromatography (9:1 
toluene-acetone) to yield 21 (82 mg, 33%) as a colourless syrup. 
 
Compound 21 was also prepared from acceptor 20 (250 mg, 0.19 mmol, 1.5 equiv) and donor 
2 (92 mg, 0.13 mmol, 1 equiv) in dry CH2Cl2 (10 mL) by method C using NIS (35 mg, 1.2 
equiv) and TfOH (4.7 µL, 0.05 mmol, 0.4 equiv). The crude product was purified by column 
chromatography (9:1 toluene-acetone) to yield 21 (25 mg, 10%) as a colourless syrup. []D 
+24.4 (c 0.38 CHCl3); Rf 0.37 (9:1 toluene-acetone); 1H NMR (400 MHz, CDCl3) δ 8.15-7.00 
(m, 55H, Ph), 6.74, 6.55 (2 x d, 4H, PMP), 5.61 (t, 1H, J2,3 8.2 Hz, H-1), 5.47 (t, 1H, J2’,3’ 8.9 
Hz, H-1’), 5.41 (d, 1H, J1”,2” 3.5 Hz, H-1”), 4.98-4.17 (m, 28H, 7 x CH2Ph, H-5”, H-1, H-1’, 
H-6a,b, H-6’a,b, H-4”, H-7’’’a,b, H-6’’’, H-3, H-4’’’, H-3”), 4.11-3.98 (m, 4H, H-4, H-3’, 
SO3CH2CH3), 3.95-3.84 (m, 2H, H-2”, H-5’’’), 3.78-3.57 (m, 4H, H-4’, H-3’’’, H-5, H-5’), 
3.64 (s, 3H, OCH3), 3.28 (s, 1H, H-4’-OH), 3.15-3.04 (m, 2H, H-1’’’a,b), 1.40 (d, 3H, J5”,6” 
6.5 Hz, H-6”), 1.10 (t, 3H, J 7.0 Hz, SO3CH2CH3); 13C NMR (100 MHz, CDCl3) δ 166.3, 
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165.9, 164.4 (4C, CO), 155.4, 151.1 (2C, Cq, PMP), 139.3-137.3 (7C, Cq, Ph), 129.8-126.7 
(55C, Ph), 118.7, 114.2 (4C, PMP), 100.1, 100.4, 97.7 (C-1, C-1’, C-1”), 99.8 (C-2’”), 82.8, 
82.4, 80.9, 78.9, 78.8, 77.9, 75.6, 74.5, 74.4, 73.5, 72.8, 71.9, 71.5, 70.6, 67.8, 66.6, (skeleton 
carbons), 75.2, 75.1, 74.9, 73.4, 73.1, 72.6, 72.3 (7C, CH2Ph), 68.4, 68.1 (C-6’’’, 
SO3CH2CH3), 62.6, 62.2 (C-6, C-6’), 55.4 (OCH3), 53.3 (C-1’’’, 3JC1’’’,H3’’’ ≤ 1 Hz), 16.5 (C-
6”), 15.0 (SO3CH2CH3). MALDI-TOF m/z Calcd for C111H112NaO28S [M+Na]+: 1947.70, 
Found: 1948.25. Anal. Calcd for C111H112O28S (1924.71): C, 69.22; H, 5.86; S, 1.66. Found: 
C, 69.21; H, 5.84; S, 1.64. 
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Table 1. Glycosylation of methanol with 1-deoxy-1-ethloxysulfonyl-hept-2-ulopyranosyl 
donors 
 
aAmount of promoters: NIS (1.2 equiv) TfOH (0.4 equiv); Hg(CN)2 (1 equiv); AgOTf (2 
equiv); Hg(CN)2 (1.5 equiv) HgBr2 (0.5 equiv). 
 
Donor Promotera T (°C) Time 5 (%) 6 (%) 7 (%) 8 (%) 
2 NIS-TfOH -60 40 min 43 57 - - 
2 NIS-TfOH 0 40 min 62 38 - - 
2 NIS-TfOH rt 30 min 69 31 - - 
3 AgOTf -40 to -10 20 min 81.3 17.6 0.7 0.4 
3 Hg(CN)2 0 20 min 65.2 33.1 1.6 - 
4 AgOTf -40 to -10 5 h 80.7 12.0 5.4 1.9 
4 Hg(CN)2-HgBr2 0 to rt 5 h 84.9 9.5 5.6 - 
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Table 2. Glycosylation of 9 with 1-deoxy-1-ethoxysulfonyl-hept-2-ulopyranosyl donors 
 
Donor Promotera T (°C) Time 10 (%) 11 (%) 7 (%) 8 (%) 
2 NIS-TfOH -50 1 h 81.6 6.7 11.7 - 
2 NIS-TfOH -5 30 min 74.4 7.7   
3 AgOTf -15 7.5 h 63.6 24.0 12.4b 
3 Hg(CN)2 0 3 h 55.2 19.4 25.4b 
4 AgOTf -15 8 h 71.5 6.3 19.8 2.4 
4 Hg(CN)2-HgBr2 0 18 h 55.8 19.6 24.6b 
4 Hg(CN)2 rt 18 h 11.3 8.5 57.1 23.1 
aAmount of promoters: NIS (1.2 equiv) TfOH (0.4 equiv); Hg(CN)2 (1 equiv); AgOTf (2 
equiv); Hg(CN)2 (1.5 equiv) HgBr2 (0.5 equiv); bRatio of 7 and 8 was not determined. 
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Table 3. Glycosylation of 12 with 1-deoxy-1-ethoxysulfonyl-hept-2-ulopyranosyl donors 
 
Donor Promotera T (°C) Time 14 (%) 7 (%) 8 (%) 
2 NIS-TfOH -40 30 min 17.4 55.1 27.5 
2 NIS-TfOH 0 2 h 0.6 99.4b 
2 MeOTf rt 1 day 23.2 76.8b 
3 AgOTf 0 1 h 28.6 40.8 30.6 
3 Hg(CN)2 0 1h 39.6 35.0 25.4 
4 AgOTf 0 1h 40.0 45.2 14.8 
4 Hg(CN)2-HgBr2 0 4 days 11.2 62.0 26.8 
aAmount of promoters: NIS (1.2 equiv) TfOH (0.4 equiv); MeOTf (6 equiv); AgOTf (2 
equiv); Hg(CN)2 (1 equiv); Hg(CN)2 (1.5 equiv) HgBr2 (0.5 equiv). bRatio of 7 and 8 was not 
determined. 
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Table 4. Glycosylation of 13 with 1-deoxy-1-ethoxysulfonyl-hept-2-ulopyranosyl donors 
 
Donor Promotera T (°C) Time 15 (%) 7 (%) 8 (%) 
2 NIS-TfOH -40 65 min 12.0 86.1 1.9 
2 MeOTf RT 1 day 18.5 81.5b 
3 AgOTf 0 2 h 13.5 30.5 56.0 
3 Hg(CN)2 0 2.5 h 16.2 29.3 54.5 
4 AgOTf 0 2 days 63.4 29.1 7.5 
4 Hg(CN)2-HgBr2 0 5 days 16.3 50.7 33.0 
aAmount of promoters: NIS (1.2 equiv) TfOH (0.4 equiv); MeOTf (6 equiv); AgOTf (2 
equiv); Hg(CN)2 (1 equiv); Hg(CN)2 (1.5 equiv) HgBr2 (0.5 equiv). bRatio of 7 and 8 was not 
determined. 
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